Corporate Governance | Regeneron Pharmaceuticals Inc.

Date	Name	Title	Filing	Type	Shares Traded	Price	Total Held
Dec 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$818.76	18,489
Dec 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$821.92	18,471
Dec 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$825.38	18,459
Dec 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$827.61	18,447
Aug 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$732.76	18,745
Aug 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$741.42	18,648
Jun 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$730.03	18,945
Jun 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$733.61	18,924
May 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$804.51	18,999
Feb 01, 2023	RYAN ARTHUR F Director	Director	Form 4	Open market or private sale of non-derivative or derivative security	2	$752.11	19,345

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.

Investors & Media